Venmax Drugs Pharmaceuticals Ltd vs Vista Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Venmax Drugs & Pharmaceuticals Ltd is ₹ 23.66 as of 05 May 15:30 . The P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Vista Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 14.94 crore on March 2025 to ₹ 14.94 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Vista Pharmaceuticals Ltd changed from ₹ 33.26 crore on March 2021 to ₹ 39.52 crore on March 2025 . This represents a CAGR of 3.51% over 5 years The revenue of Venmax Drugs & Pharmaceuticals Ltd for the Dec '25 is ₹ 1.62 crore as compare to the Sep '25 revenue of ₹ 1.32 crore. This represent the growth of 22.73% The revenue of Vista Pharmaceuticals Ltd for the Dec '25 is ₹ 2.51 crore as compare to the Sep '25 revenue of ₹ 1.65 crore. This represent the growth of 52.12% The ebitda of Venmax Drugs & Pharmaceuticals Ltd for the Dec '25 is ₹ 0.04 crore as compare to the Sep '25 ebitda of ₹ 0.05 crore. This represent the decline of -20% The ebitda of Vista Pharmaceuticals Ltd for the Dec '25 is ₹ -2.92 crore as compare to the Sep '25 ebitda of ₹ -3.25 crore. This represent the decline of -10.15% The net profit of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 0.01 crore to ₹ 0.03 crore over 7 quarters. This represents a CAGR of 87.34% The net profit of Vista Pharmaceuticals Ltd changed from ₹ -0.86 crore to ₹ -2.32 crore over 7 quarters. This represents a CAGR of 76.31% The Dividend Payout of Venmax Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vista Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998.
The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'.
Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D.

About Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991.
The Company is engaged in the formulation of pharmaceutical products.
It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments.
This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India. The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.
Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.

FAQs for the comparison of Venmax Drugs & Pharmaceuticals Ltd and Vista Pharmaceuticals Ltd

Which company has a larger market capitalization, Venmax Drugs & Pharmaceuticals Ltd or Vista Pharmaceuticals Ltd?

Market cap of Venmax Drugs & Pharmaceuticals Ltd is 27 Cr while Market cap of Vista Pharmaceuticals Ltd is 49 Cr

What are the key factors driving the stock performance of Venmax Drugs & Pharmaceuticals Ltd and Vista Pharmaceuticals Ltd?

The stock performance of Venmax Drugs & Pharmaceuticals Ltd and Vista Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Venmax Drugs & Pharmaceuticals Ltd and Vista Pharmaceuticals Ltd?

As of May 5, 2026, the Venmax Drugs & Pharmaceuticals Ltd stock price is INR ₹23.66. On the other hand, Vista Pharmaceuticals Ltd stock price is INR ₹7.98.

How do dividend payouts of Venmax Drugs & Pharmaceuticals Ltd and Vista Pharmaceuticals Ltd compare?

To compare the dividend payouts of Venmax Drugs & Pharmaceuticals Ltd and Vista Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.